{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:55:15Z","timestamp":1792173315097,"version":"4.4.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"10-11","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.addr.2011.05.017","type":"journal-article","created":{"date-parts":[[2011,6,26]],"date-time":"2011-06-26T17:22:37Z","timestamp":1309108957000},"page":"901-908","source":"Crossref","is-referenced-by-count":223,"title":["Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles"],"prefix":"10.1016","volume":"63","author":[{"given":"Shuang","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taryn R.","family":"Bagby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Laird","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2011.05.017_bb0005","first-page":"2528","article-title":"Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery","volume":"6","author":"Harrington","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2011.05.017_bb0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbamem.2007.08.033","article-title":"Enhanced lymph node retention of subcutaneously injected IgG1-PEG2000-liposomes through pentameric IgM antibody-mediated vesicular aggregation","volume":"1778","author":"Moghimi","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2011.05.017_bb0015","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.biomaterials.2005.05.082","article-title":"The effect of methoxy-PEG chain length and molecular architecture on lymph node targeting of immuno-PEG liposomes","volume":"27","author":"Moghimi","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2011.05.017_bb0020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0022-3565(24)38903-7","article-title":"Novel method of greatly enhanced delivery of liposomes to lymph nodes","volume":"295","author":"Phillips","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2011.05.017_bb0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1248\/bpb1978.7.195","article-title":"Intestinal absorption of carboxyfluorescein entrapped in liposomes in comparison with its administration with lipid\u2013surfactant mixed micelles","volume":"7","author":"Hashida","year":"1984","journal-title":"J. Pharmacobiodyn."},{"key":"10.1016\/j.addr.2011.05.017_bb0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1081\/LPR-120004792","article-title":"Liposome (Lipodine)-mediated DNA vaccination by the oral route","volume":"12","author":"Perrie","year":"2002","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.addr.2011.05.017_bb0035","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3181\/0901-RM-8","article-title":"Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases","volume":"234","author":"Latimer","year":"2009","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.addr.2011.05.017_bb0040","first-page":"261","article-title":"Nanoradioliposomes molecularly modulated to study the lung deep lymphatic drainage","volume":"15","author":"Rabaca Roque Botelho","year":"2009","journal-title":"Rev. Port. Pneumol."},{"key":"10.1016\/j.addr.2011.05.017_bb0045","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.acra.2005.08.024","article-title":"Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure","volume":"13","author":"Frenkel","year":"2006","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.addr.2011.05.017_bb0050","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/annonc\/mdh097","article-title":"Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX\/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer","volume":"15","author":"O'Brien","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.addr.2011.05.017_bb0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1586\/14737140.2.2.143","article-title":"Caelyx\/Doxil for the treatment of metastatic ovarian and breast cancer","volume":"2","author":"Tejada-Berges","year":"2002","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.addr.2011.05.017_bb0060","first-page":"43","article-title":"Doxil offers hope to KS sufferers","volume":"1","author":"Prescott","year":"1995","journal-title":"J. Int. Assoc. Physicians AIDS Care"},{"key":"10.1016\/j.addr.2011.05.017_bb0065","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.nucmedbio.2009.02.004","article-title":"[(186)Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model","volume":"36","author":"Soundararajan","year":"2009","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.addr.2011.05.017_bb0070","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/10611860400027725","article-title":"Lymphatic chemotherapy induces apoptosis in lymph node metastases in a rabbit breast carcinoma model","volume":"13","author":"Ling","year":"2005","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2011.05.017_bb0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0168-3659(97)00104-1","article-title":"Massage-induced release of subcutaneously injected liposome-encapsulated drugs to the blood","volume":"50","author":"Trubetskoy","year":"1998","journal-title":"J. Control Release"},{"key":"10.1016\/j.addr.2011.05.017_bb0080","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/03639040500519102","article-title":"Enhanced oral bioavailability and intestinal lymphatic transport of a hydrophilic drug using liposomes","volume":"32","author":"Ling","year":"2006","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2011.05.017_bb0085","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1128\/IAI.72.10.5963-5971.2004","article-title":"Magnetic resonance imaging of pulmonary lesions in guinea pigs infected with Mycobacterium tuberculosis","volume":"72","author":"Kraft","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2011.05.017_bb0090","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00280-004-0817-y","article-title":"Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis","volume":"54","author":"Lawson","year":"2004","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.addr.2011.05.017_bb0095","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1023\/B:PHAM.0000029292.66792.4f","article-title":"Coating of mannan on LPD particles containing HPV E7 peptide significantly enhances immunity against HPV-positive tumor","volume":"21","author":"Cui","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2011.05.017_bb0100","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0076-6879(05)91019-7","article-title":"Lymphoid tissue targeting of anti-HIV drugs using liposomes","volume":"391","author":"Desormeaux","year":"2005","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.addr.2011.05.017_bb0105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0005-2736(00)00254-6","article-title":"Sterically stabilized liposomes bearing anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1","volume":"1468","author":"Bestman-Smith","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2011.05.017_bb0110","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0022-3565(24)29491-X","article-title":"Immune stimulation by a CpG-containing oligodeoxynucleotide is enhanced when encapsulated and delivered in lipid particles","volume":"298","author":"Mui","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2011.05.017_bb0115","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00262-006-0276-x","article-title":"Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN","volume":"56","author":"de Jong","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.addr.2011.05.017_bb0120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2008.03.023","article-title":"Oligomannose-coated liposomes as a therapeutic antigen-delivery and an adjuvant vehicle for induction of in vivo tumor immunity","volume":"129","author":"Kojima","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2011.05.017_bb0125","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.1200\/JCO.2005.13.011","article-title":"Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer","volume":"23","author":"Butts","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.addr.2011.05.017_bb0130","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.vaccine.2003.08.021","article-title":"Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Ep-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factor","volume":"22","author":"Neidhart","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2011.05.017_bb0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1081\/LPR-120004779","article-title":"Assessment of liposome delivery using scintigraphic imaging","volume":"12","author":"Phillips","year":"2002","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.addr.2011.05.017_bb0140","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0969-8051(01)00198-6","article-title":"Evaluation of [(99m)Tc] liposomes as lymphoscintigraphic agents: comparison with [(99m)Tc] sulfur colloid and [(99m)Tc] human serum albumin","volume":"28","author":"Phillips","year":"2001","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.addr.2011.05.017_bb0145","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/jso.21581","article-title":"Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute","volume":"101","author":"Bagaria","year":"2010","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.addr.2011.05.017_bb0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF02936375","article-title":"Intestinal Beh\u00e7et's disease associated with non-Hodgkin's lymphoma","volume":"32","author":"Yamamoto","year":"1997","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.addr.2011.05.017_bb0155","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/RLU.0b013e3181b06cc5","article-title":"Progression of clinically stable lymphedema on lymphoscintigraphy","volume":"34","author":"Luongo","year":"2009","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.addr.2011.05.017_bb0160","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/RLU.0b013e3181a7d013","article-title":"Lymphoscintigraphy in angiomyomatous hamartomas and primary lower limb lymphedema","volume":"34","author":"Bourgeois","year":"2009","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.addr.2011.05.017_bb0165","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/jps.10170","article-title":"Kit formulation for the preparation of radioactive blue liposomes for sentinel node lymphoscintigraphy","volume":"91","author":"Plut","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2011.05.017_bb0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1248\/bpb.23.97","article-title":"Magnetic resonance lymphography of profundus lymph nodes with liposomal gadolinium-diethylenetriamine pentaacetic acid","volume":"23","author":"Fujimoto","year":"2000","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.addr.2011.05.017_bb0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/0284185197038412S01","article-title":"Interstitial MR lymphography using Gd-carrying liposomes","volume":"412","author":"Misselwitz","year":"1997","journal-title":"Acta Radiol. Suppl."},{"key":"10.1016\/j.addr.2011.05.017_bb0180","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0730-725X(94)00083-F","article-title":"Controlled delivery of Gd-containing liposomes to lymph nodes: surface modification may enhance MRI contrast properties","volume":"13","author":"Trubetskoy","year":"1995","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.addr.2011.05.017_bb0185","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijpharm.2007.01.010","article-title":"Use of avidin\/biotin-liposome system for enhanced peritoneal drug delivery in an ovarian cancer model","volume":"337","author":"Zavaleta","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2011.05.017_bb0190","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1002\/jps.20163","article-title":"Avidin\/biotin-liposome system injected in the pleural space for drug delivery to mediastinal lymph nodes","volume":"93","author":"Medina","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2011.05.017_bb0195","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jps.20516","article-title":"Mediastinal node and diaphragmatic targeting after intracavitary injection of avidin\/99mTc-blue-biotin-liposome system","volume":"95","author":"Medina","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2011.05.017_bb0200","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery\u2014a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2011.05.017_bb0205","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2011.05.017_bb0210","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.addr.2007.04.008","article-title":"Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles","volume":"59","author":"Wong","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2011.05.017_bb0215","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jconrel.2005.02.028","article-title":"Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice","volume":"105","author":"Harivardhan Reddy","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2011.05.017_bb0220","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.nano.2008.08.003","article-title":"Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery","volume":"5","author":"Paliwal","year":"2009","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2011.05.017_bb0225","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/jps.10129","article-title":"Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats","volume":"91","author":"Zara","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2011.05.017_bb0230","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/scientificamerican0794-58","article-title":"Barriers to drug delivery in solid tumors","volume":"271","author":"Jain","year":"1994","journal-title":"Sci. Am."},{"key":"10.1016\/j.addr.2011.05.017_bb0235","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1023\/A:1011975120776","article-title":"Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats","volume":"15","author":"Bargoni","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2011.05.017_bb0240","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1006\/phrs.2000.0737","article-title":"Transmucosal transport of tobramycin incorporated in SLN after duodenal administration to rats. Part I\u2014a pharmacokinetic study.","volume":"42","author":"Cavalli","year":"2000","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.addr.2011.05.017_bb0245","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/jps.10368","article-title":"Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin","volume":"92","author":"Cavalli","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2011.05.017_bb0250","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/1061186021000054933","article-title":"Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles","volume":"10","author":"Videira","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2011.05.017_bb0255","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1200\/JCO.1987.5.2.246","article-title":"Metastatic patterns in small-cell lung cancer: correlation of autopsy findings with clinical parameters in 537 patients","volume":"5","author":"Elliott","year":"1987","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.addr.2011.05.017_bb0260","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1080\/028418699432248","article-title":"Metastatic pattern in non-resectable non-small cell lung cancer","volume":"38","author":"Stenbygaard","year":"1999","journal-title":"Acta Oncol."},{"key":"10.1016\/j.addr.2011.05.017_bb0265","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0169-409X(95)00045-9","article-title":"Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristics","volume":"17","author":"Hawley","year":"1995","journal-title":"Adv Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2011.05.017_bb0270","series-title":"Lymphatic Transport of Drugs","author":"Charman","year":"1992"},{"key":"10.1016\/j.addr.2011.05.017_bb0275","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0005-2736(97)00122-3","article-title":"Lymphatic uptake and biodistribution of liposomes after subcutaneous injection.: II. Influence of liposomal size, lipid composition and lipid dose","volume":"1328","author":"Oussoren","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2011.05.017_bb0280","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/10611860902718672","article-title":"Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement","volume":"17","author":"Sanjula","year":"2009","journal-title":"J. Drug Target."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X11001396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X11001396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T18:33:29Z","timestamp":1741286009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X11001396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":56,"journal-issue":{"issue":"10-11","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0169409X11001396"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2011.05.017","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}